Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

Author： Eap Chin   Buclin Thierry   Hustert Elisabeth   Bleiber Gabriela   Golay Kerry   Aubert Anne-Catherine   Baumann Pierre   Telenti Amalio   Kerb Reinhold  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.60, Iss.4, 2004-06, pp. : 231-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 151-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Statin regulation of CYP3A4 and CYP3A5 expression

By Willrich Maria Alice Vieira   Hirata Mario Hiroyuki   Hirata Rosario Dominguez Crespo  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 1017-1024

Future Medicine

Access to resources Recommend Favorite

Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43

By Krusekopf S.   Roots I.   Kleeberg U.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 7-12

Elsevier

Access to resources Recommend Favorite

Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism

By de Jonge Hylke   de Loor Henriette   Verbeke Krisitin   Vanrenterghem Yves   Kuypers Dirk RJ  

Pharmacogenomics, Vol. 14, Iss. 12, 2013-09 ,pp. : 1467-1480

Future Medicine

Access to resources Recommend Favorite

Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs

By  

Current Drug Metabolism, Vol. 17, Iss. 3, 2016-03 ,pp. : 227-236

Bentham Science Publishers

Access to resources Recommend Favorite